HOME > TOP STORIES
TOP STORIES
-
BUSINESS Gilead Set to Duplicate Biktarvy Success in Japan with New Stand-Alone HIV Sales Force
March 20, 2019
-
BUSINESS Employee Sues Bayer Japan for Emotional Distress over Xarelto Scandal
March 19, 2019
-
ORGANIZATION Kenporen Director Kono: Apply CEA to Reimbursement Decisions Once Credible System Established
March 18, 2019
-
BUSINESS Drug Makers, Wholesalers Establishing Supervisory Divisions as Detailing Guidelines Rollout Nears
March 15, 2019
-
REGULATORY MHLW to Promote Master Protocol Trials to Boost Efficiency in New Drug Development
March 14, 2019
-
BUSINESS Fujifilm Going Full Throttle in CDMO Biz with Buyout of Biogen Unit
March 13, 2019
-
REGULATORY Detailing Guidelines Casting Clouds over Drug Maker-Sponsored Press Seminars?
March 12, 2019
-
BUSINESS Meiji Pharma Pursuing Low-Cost Strategy to Weather Storm in Generics Space, Overseas Plants Hold Key
March 11, 2019
-
BUSINESS Eisai CEO Says “20% ROE in 2025” within Reach If All 3 Alzheimer’s Candidates, Lenvima Deliver
March 8, 2019
-
INTERVIEW JMA Exec Matsumoto: CEA Scheme Merely a Supplemental Tool to Drug Pricing System, Continued Discussions Necessary
March 7, 2019
-
BUSINESS Pfizer Japan Logs 2.6% Growth in FY2018, No Job Cut Planned: Chief
March 6, 2019
-
TRENDS Drug Makers on Hunt for “Mibyo” Biz Opportunities as Pricing Rules Get Stricter
March 5, 2019
-
COMMENTARY Generic Makers Shifting to Focus on “Specialty Area” Faced with Tougher Business Environment
March 4, 2019
-
BUSINESS More Pharmacies Turning to Medical System Network’s Price Negotiation Service after Distribution Guidelines Introduced
March 1, 2019
-
REGULATORY MHLW to Impose Administrative Fines Only on Misleading Ads, Eyes 4.5% Charge: PMD Law
February 28, 2019
-
ACADEMIA Investigators Calling Off Trials on First Hyperlactacidemia Drug with No Significant Improvement Shown
February 28, 2019
-
BUSINESS Nihon Generic Taking Pass on June Listing of Symbicort Copies; 2 Partners Mum
February 27, 2019
-
BUSINESS Shionogi Specialty Squad Providing Deep Info on Mulpleta/Pirespa, Aims for Higher Sales with Fewer Calls
February 26, 2019
-
BUSINESS Takeda Japan Chief Says Shire Buy Only Bolsters Home Operations with No Overlaps, Nixes Job Cuts
February 25, 2019
-
TRENDS Industry Workforce Dwindling as More and More Staffers Take Voluntary Retirement; Astellas Could Cut 700 Jobs
February 22, 2019
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
